{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.15","value":"14.9"},{"groupId":"OG001","spread":"0.14","value":"14.9"}]}],"title":"Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.28","value":"13.5"},{"groupId":"OG001","spread":"0.27","value":"11.3"}]}],"title":"6 Weeks"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.37","value":"11.1"},{"groupId":"OG001","spread":"0.34","value":"11.2"}]}],"title":"15 Weeks"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.41","value":"9.5"},{"groupId":"OG001","spread":"0.36","value":"10.9"}]}],"title":"26 Weeks"}],"denoms":[{"counts":[{"groupId":"OG000","value":"228"},{"groupId":"OG001","value":"246"}],"units":"Participants"}],"description":"The FACT/GOG-Ntx subscale (short version) contains 4 items measuring sensory neuropathy. Each item is scored using a 5-point Likert scale (0=not at all; 1= a little bit; 2=somewhat; 3=quite a bit; 4=very much). For east item, reversal was performed prior to score calculation so that a large score suggests less symptom. according to the FACIT measurement system, the subscale score was calculated as the summation of the individual item scores if more than 50% of subscale items were answered. When unanswered items existed, a subscale score was prorated by multiplying the mean of the answered item scores by the number of items in the subscale. The Ntx subscale score ranges 0-16 with a large subscale score suggests less symptom or better QOL (Quality of Life).","dispersionType":"Standard Error","groups":[{"description":"Patients receive doxorubicin IV over approximately 15-30 minutes on day 1, cisplatin IV over 60-90 minutes on day 1, paclitaxel IV over 3 hours on day 2, and filgrastim SC on days 3-12 or pegfilgrastim SC on day 3. Treatment repeats every 21 days for 7 courses in the absence of disease progression or unacceptable toxicity.","id":"OG000","title":"Doxorubicin, Cisplatin, Paclitaxel"},{"description":"Patients receive paclitaxel IV over 3 hours and carboplatin IV over 30-60 minutes on day 1. Treatment repeats every 21 days for 7 courses in the absence of disease progression or unacceptable toxicity.","id":"OG001","title":"Paclitaxel, Carboplatin"}],"paramType":"LEAST_SQUARES_MEAN","populationDescription":"Eligible and evaluable and enrolled prior to 3/26/2006","reportingStatus":"POSTED","timeFrame":"Baseline, 6 weeks post treatment start, 15 weeks post treatment start and 26 weeks post treatment start","title":"Patient-reported Neurotoxicity (Ntx) as Measured by the FACT/GOG-Ntx Subscale (Short)","type":"SECONDARY","unitOfMeasure":"units on a scale"}